Hearing Loss Pipeline Assessment, 2024 Updates: FDA, EMA, and PMDA Approvals, Emerging Drugs, Clinical Trials, and Growth Prospects | Anida Pharma, Autifony Therapeutics, Applied Genetic Technologies Corporation, Acousia Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Hearing Loss pipeline constitutes 32+ key companies continuously working towards developing 35+ Hearing Loss treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Hearing Loss Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Hearing Loss Market.

The Hearing Loss Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Hearing Loss Pipeline Report: https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Hearing Loss treatment therapies with a considerable amount of success over the years.
• Hearing Loss companies working in the treatment market are Anida Pharma, Autifony Therapeutics, Applied Genetic Technologies Corporation, Acousia Therapeutics, Decibel Therapeutics, Otonomy, Inc, Pipeline Therapeutics, Sensorion, Sound Pharmaceuticals, and others, are developing therapies for the Hearing Loss treatment
• Emerging Hearing Loss therapies in the different phases of clinical trials are- AP001, Research programme-Hearing Loss, Research program-GJB2, ACOU085, DB-020, OTO 413, PIPE 505, SENS-401, SPI-1005, and others are expected to have a significant impact on the Hearing Loss market in the coming years.
• In January 2024, Akouos, Inc., a subsidiary of Eli Lilly and Company (NYSE: LLY), has reported encouraging preliminary findings from the Phase 1/2 AK-OTOF-101 trial. The study showcased pharmacological restoration of hearing within 30 days of AK-OTOF administration in the initial participant, who had suffered from profound hearing loss for over a decade. Additional data from a second participant receiving AK-OTOF will also be unveiled at the Late Breaking Presidential Symposium during the 2024 Association for Research in Otolaryngology (ARO) MidWinter Meeting.
• InOctober 2023, The German Regulatory Authorities (BfArM) have authorized Acousia Therapeutic's Phase II trial aimed at addressing cisplatin-induced hearing loss in patients. ACOU085, an otoprotectant with a broad scope, aims to mitigate the ototoxicity associated with cisplatin, a chemotherapy agent used in various cancer treatments such as those for testicular, ovarian, and cervical cancers. Ototoxicity, a significant side effect of cisplatin, often results in irreversible hearing impairment among affected patients.
• In August 2022, Sound Pharmaceuticals has commenced a Phase III clinical trial involving a randomized, double-blind, placebo-controlled, multi-center investigation to assess the safety and effectiveness of SPI-1005 in treating Meniere's disease. Additionally, an open-label extension study has been initiated to examine the long-term safety of SPI-1005. The primary objectives of these trials are to gauge the occurrence of treatment-emergent adverse events, measure changes in low-frequency hearing thresholds using pure-tone audiometry, and assess various other endpoints.


Hearing Loss Overview
Hearing loss, also known as hearing impairment or deafness, refers to a partial or total inability to hear sounds. It can affect one or both ears and can range from mild to profound. Hearing loss can occur at any age and may be temporary or permanent.

Get a Free Sample PDF Report to know more about Hearing Loss Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Hearing Loss Drugs Under Different Phases of Clinical Development Include:
• AP001: Anida Pharma
• Research programme: Hearing Loss: Autifony Therapeutics
• Research program: GJB2 Applied Genetic Technologies Corporation
• ACOU085: Acousia Therapeutics
• DB-020: Decibel Therapeutics
• OTO 413: Otonomy, Inc
• PIPE 505: Pipeline Therapeutics
• SENS-401: Sensorion
• SPI-1005: Sound Pharmaceuticals

Hearing Loss Route of Administration
Hearing Loss pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Intravenous
• Subcutaneous
• Parenteral
• Topical

Hearing Loss Molecule Type
Hearing Loss Products have been categorized under various Molecule types, such as
• Recombinant fusion proteins
• Small molecule
• Monoclonal antibody
• Peptide
• Polymer
• Gene therapy

Hearing Loss Pipeline Therapeutics Assessment
• Hearing Loss Assessment by Product Type
• Hearing Loss By Stage and Product Type
• Hearing Loss Assessment by Route of Administration
• Hearing Loss By Stage and Route of Administration
• Hearing Loss Assessment by Molecule Type
• Hearing Loss by Stage and Molecule Type

DelveInsight's Hearing Loss Report covers around 35+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Hearing Loss product details are provided in the report. Download the Hearing Loss pipeline report to learn more about the emerging Hearing Loss therapies at:
https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Hearing Loss Therapeutics Market include:
Key companies developing therapies for Hearing Loss are - Phonak Hearing Systems, Resound, Widex, Oticon, Siemens AG, Starkey Hearing Technologies, Audina Hearing Instruments, Cochlear Ltd, Amplifon, GN Hearing, and others.

Hearing Loss Pipeline Analysis:
The Hearing Loss pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Hearing Loss with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Hearing Loss Treatment.
• Hearing Loss key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Hearing Loss Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Hearing Loss market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Hearing Loss drugs and therapies-
https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Hearing Loss Pipeline Market Drivers
• Rapidly growing incidence of acute sensorineural hearing loss, rise in geriatric population, increasing noise pollution are some of the important factors that are fueling the Hearing Loss Market.

Hearing Loss Pipeline Market Barriers
• However, challenges associated with the delivery of therapeutics for Sensorineural Hearing Loss, poor understanding of the specific underlying pathologies and other factors are creating obstacles in the Hearing Loss Market growth.

Scope of Hearing Loss Pipeline Drug Insight
• Coverage: Global
• Key Hearing Loss Companies: Anida Pharma, Autifony Therapeutics, Applied Genetic Technologies Corporation, Acousia Therapeutics, Decibel Therapeutics, Otonomy, Inc, Pipeline Therapeutics, Sensorion, Sound Pharmaceuticals, and others
• Key Hearing Loss Therapies: AP001, Research programme-Hearing Loss, Research program-GJB2, ACOU085, DB-020, OTO 413, PIPE 505, SENS-401, SPI-1005, and others
• Hearing Loss Therapeutic Assessment: Hearing Loss current marketed and Hearing Loss emerging therapies
• Hearing Loss Market Dynamics: Hearing Loss market drivers and Hearing Loss market barriers

Request for Sample PDF Report for Hearing Loss Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/hearing-loss-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Hearing Loss Report Introduction
2. Hearing Loss Executive Summary
3. Hearing Loss Overview
4. Hearing Loss- Analytical Perspective In-depth Commercial Assessment
5. Hearing Loss Pipeline Therapeutics
6. Hearing Loss Late Stage Products (Phase II/III)
7. Hearing Loss Mid Stage Products (Phase II)
8. Hearing Loss Early Stage Products (Phase I)
9. Hearing Loss Preclinical Stage Products
10. Hearing Loss Therapeutics Assessment
11. Hearing Loss Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Hearing Loss Key Companies
14. Hearing Loss Key Products
15. Hearing Loss Unmet Needs
16 . Hearing Loss Market Drivers and Barriers
17. Hearing Loss Future Perspectives and Conclusion
18. Hearing Loss Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:
Hearing Loss Epidemiology https://www.delveinsight.com/report-store/hearing-loss-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Hearing Loss Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:

Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others

B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.